Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cell surface vimentin‐positive circulating tumor cell‐based relapse prediction in a long‐term longitudinal study of postremission neuroblastoma patients

7 Jun 2020

Abstract excerpt

Abstract Neuroblastoma (NB) is a deadly childhood disease that carries a 50% chance of relapse for anyone in remission and similar level of 5‐year survival. We investigated the value of our proprietary approach—cell surface vimentin (CSV) positive circulating tumor cells (CTC) to monitor treatment response and predict relapse in NB patients under remission in a Phase II long‐term preventative clinical trial. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lung Cancer Research Studies
Share to Neuroblastoma Research and Treatments
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32506485
DOI: 10.1002/ijc.33140

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cell surface vimentin‐positive circulating tumor cell‐based relapse prediction in a long‐term longitudinal study of postremission neuroblastoma patientsPMID 32506485Read ↗

Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progressionSemantic proximity Read ↗

Identification and Characterization of Chemotherapy-Resistant High-Risk Neuroblastoma Persister CellsSemantic proximity Read ↗

Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastomaSemantic proximity Read ↗

Mesenchymal Transition as a Potential Mechanism of Late Immune Evasion in Neuroblastoma: A Case of Late Relapse after Allogeneic Hematopoietic Stem Cell TransplantationSemantic proximity Read ↗

A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastomaSemantic proximity Read ↗

Metastatic tumor cells in bone marrow differ from paired neuroblastoma tumor and contain subsets with therapy-resistant characteristicsSemantic proximity Read ↗

Novel Therapies for Relapsed and Refractory NeuroblastomaSemantic proximity Read ↗

Survival in patients with high-risk neuroblastoma treated without autologous stem cell transplant or dinutuximab betaSemantic proximity Read ↗

Evaluation of Minimal Residual Disease in Patients with NeuroblastomaSemantic proximity Read ↗

Impact of Disseminated Neuroblastoma Cells on the Identification of the Relapse-Seeding Clone.Semantic proximity Read ↗

Single-cell next-generation sequencing of circulating tumor cells in patients with neuroblastoma.Semantic proximity Read ↗

G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.